Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease
Shelly Tartakover Matalon(Tel Aviv University), Timna Naftali(Tel Aviv University), Liat Drucker(Meir Medical Center), Shaul Pery(Meir Medical Center), Yehuda Ringel(Meir Medical Center), Fred M. Konikoff(Tel Aviv University)
Cited by 18
Related Papers
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
The Burden of Gastrointestinal and Liver Diseases, 2006
|The American Journal of Gastroenterology|2006|700
Severe defect in clearing postprandial chylomicron remnants in dialysis patients
|Kidney International|1992|77
High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
|European Journal of Surgical Oncology|2006|63
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
|The FASEB Journal|2007|56